Humans are the heart of our research.
With this motto in mind, FBM-PHARMA GmbH focuses on the production and development of personalized medicine based on autologous substances with focus on autologous serum eye drops in the treatment of various eye diseases.
We look for individualised solutions to restore your health. The continuous development of patient-specific therapies and a traditionally high quality awareness are a matter of fact for us. Our goal is to offer physicians and patients alternative methods of being cured by breaking new ground. We feel directly responsible for the patient and pursue his / her development by direct contact with him / her and his / her supervising therapist.
High-quality products and individual therapy regimens are the pillars of this special form of the individual immunotherapy. We want to offer sick people full-scale treatment with well-tolerated drugs.
Close cooperation with trusted therapists using different therapies ensures patients the best possible care whose recovery is our main focus.
The huge amount of positive feedback from our patients is a daily incentive to continue to work with great commitment for the recovery of sick people.
With our forms of therapy, we want to contribute to the fight against the constant increase of allergic and autoimmune diseases. In this regard, activating the self-healing powers of each patient by means of our drugs comes first.
A sensible combination of scientific knowledge in immunology and the experience of naturopathy, it is our endeavour to help many patients gently achieves a higher quality of life with well-tolerated drugs.
To carry out our vision, we focus on the research and development of other forms of therapies to treat additional disease patterns with the individual immunotherapy.
The individual immunotherapeutics are all prepared at our company site in Ludwigshafen / Rhine. FBM-PHARMA GmbH has an EU manufacturing permit for the preparations of drugs using one's own blood and urine and is subject to guidelines for drug-producing plants. Compliance with and continuous optimisation of our quality standards in the fields of drug preparation and corporate management, which are regularly revised by the relevant state authority, are a matter of course.
We meet the highest standards during the preparation of each individual drug. Production in qualified clean rooms and the use of qualified and continuously trained employees guarantee the patient's optimal safety for obtaining a high quality product. Due to the autologous (patient's own) nature of the source materials (blood, plasm and urine) as well as the individual preparation and bottling process, the production of the drugs is exclusively done manually.
All source materials necessary for the production process are quality-tested before use. The production process itself takes place according to the strictly-controlled principles of the drug industry that apply to the preparation of parenterals (sterile preparations for injection) and, in particular, parenterals from blood products. Facilities, equipment and processes must always reflect the current state of science and technology.
Extensive final checks ensure a product that meets the highest requirements in terms of quality and microbiological parameters.
For special production conditions, computerised logistics have been developed so as to ensure that the source materials and finished products of each individual patient can be tracked at any time from entry to delivery through the use of digital codes.
Our employees identify themselves with the company. Their motivation and their own initiative ensure the continuous progress of FBM-PHARMA GmbH. Team spirit and reliability have a positive effect on the working atmosphere.
Patient safety is our top priority. Permanent training and the continued optimisation of our processes are important components of our quality management system.